Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks

The development of new therapies is an arduous, time-consuming and costly task. Furthermore, the development of many compounds runs into issues related to safety. Drug repurposing, where drugs with established safety in humans are tested and developed for efficacy in a disease other than the one for which they were developed, is gaining traction because of its potential to overcome an initial bottleneck in the drug development process. In “Bedside to Bench,” Stephen Strittmatter discusses the types of scenario in which drug repurposing may be of benefit, such as when a drug is repurposed for a new molecular target or for the same target in a different disease. In “Bench to Bedside,” Michael Pollak focuses on a recent study that suggest that biguanides that are normally used in the treatment of diabetes could have direct cyotoxic action on cancer cells with mutations in respiratory complex I. The pharmacokinetic hurdles that may need to be overcome for this to be translated to the clinic are also discussed.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Repurposing of drugs for rapid development.

References

  1. Scannell, J.W., Blanckley, A., Boldon, H. & Warrington, B. Nat. Rev. Drug Discov. 11, 191–200 (2012).

    Article  CAS  Google Scholar 

  2. DiMasi, J.A., Feldman, L., Seckler, A. & Wilson, A. Clin. Pharmacol. Ther. 87, 272–277 (2010).

    Article  CAS  Google Scholar 

  3. Arrowsmith, J. & Miller, P. Nat. Rev. Drug Discov. 12, 569 (2013).

    Article  CAS  Google Scholar 

  4. Nygaard, H.B., van Dyck, C.H. & Strittmatter, S.M. Alzheimers Res. Ther. 6, 8 (2014).

    Article  Google Scholar 

  5. Rothstein, J.D. et al. Nature 433, 73–77 (2005).

    Article  CAS  Google Scholar 

  6. Berry, J.D. et al. PLoS ONE 8, e61177 (2013).

    Article  CAS  Google Scholar 

  7. Zhou, Y. et al. Science 302, 1215–1217 (2003).

    Article  CAS  Google Scholar 

  8. Wang, X. et al. J. Neurotrauma 26, 81–95 (2009).

    Article  Google Scholar 

  9. Kopp, M.A. et al. Cell Tissue Res. 349, 119–132 (2012).

    Article  CAS  Google Scholar 

  10. Lin, T.S. & Prusoff, W.H. J. Med. Chem. 21, 109–112 (1978).

    Article  CAS  Google Scholar 

  11. Yarchoan, R. & Broder, S. N. Engl. J. Med. 316, 557–564 (1987).

    Article  CAS  Google Scholar 

  12. Nair, P. Proc. Natl. Acad. Sci. USA 110, 2430–2432 (2013).

    Article  CAS  Google Scholar 

  13. Hennequin, L.F. et al. J. Med. Chem. 49, 6465–6488 (2006).

    Article  CAS  Google Scholar 

  14. Kulkarni, J. et al. Schizophr. Res. 48, 137–144 (2001).

    Article  CAS  Google Scholar 

  15. Hilbish, K.G., Breslin, W.J., Johnson, J.T. & Sloter, E.D. Birth Defects Res. B Dev. Reprod. Toxicol. 98, 400–415 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen M Strittmatter.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Strittmatter, S. Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks. Nat Med 20, 590–591 (2014). https://doi.org/10.1038/nm.3595

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3595

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing